Contact and Investment

With the market being conservatively valued at $1-2Bn per year in potential revenues, companies in this space have recently raised sums in excess of $50M to fund their development of products. HaemO2 aims to raise £10M in a series ‘A’ round funding in late 2015/early 2016, and is interested to have discussions with potential investors.